Document is current
Any future updates will be listed below
-
Authors
Chandraprabha, Prathibha Babu
Azhagiri, Manoj Kumar K.
Venkatesan, Vigneshwaran
Magis, Wendy
Prasad, Kirti
Suresh, Sevanthy
Pai, Aswin Anand
Marepally, Srujan
Srivastava, Alok
Mohankumar, Kumarasamypet Murugesan
Martin, David I. K.
Thangavel, Saravanabhavan https://orcid.org/0000-0001-6760-4106
-
Funding
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology, India (BT/PR31616/MED/31/408/2019, BT/PR45683/MED/31/465/2022, BT/PR26901/MED/31/377/2017)
- License Information
-
More Information
Article History
Received: 12 August 2024
Accepted: 11 December 2024
First Online: 31 December 2024
Declarations
:
: The study titled “ In vivo efficacy and safety studies of CSCR-ST04, the gene edited autologous hematopoietic stem cells for the gene therapy of -hemoglobinopathies” was approved by the IRB of the Christian Medical College Vellore, with the approval number “IRB: 11807 (other) dated: 30.01.2019” and, the animal experiments were approved by the IAEC (approval number: 01/2019).
: Not applicable.
: The authors declare that they have no competing interests.
